Drug intelligence / Profile preview

estrogen + fluoxetine

Development stage
Phase 4
Lead developer
Eli Lilly
Modality
Small Molecules
Administration
Oral, Transdermal, Topical, Intravaginal, Intramuscular
01

Overview

The combination of estrogen and fluoxetine refers to the co-administration of estrogenic hormones (such as estradiol or conjugated estrogens) and the selective serotonin reuptake inhibitor (SSRI) fluoxetine. This therapeutic strategy is primarily investigated for the management of vasomotor symptoms (hot flashes) and mood disturbances associated with menopause, perimenopause, and Premenstrual Dysphoric Disorder (PMDD). Estrogen acts as an agonist at estrogen receptors to stabilize thermoregulation and maintain bone density, while fluoxetine increases synaptic serotonin levels by inhibiting the serotonin transporter (SERT), thereby alleviating depressive and anxiety symptoms. While both components are individually FDA-approved, they are typically prescribed as separate agents rather than a fixed-dose combination product.

Other names
estrogen and fluoxetinefluoxetine and estrogen combination
02

Targets

HTR2C (5-hydroxytryptamine 2C receptor)SERT (Sodium-dependent serotonin transporter)ESR1 (ERα)ESR2 (ERβ)

Beyond the preview

Go deeper on estrogen + fluoxetine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on estrogen + fluoxetine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call